BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32429636)

  • 1. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
    Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical outcomes and perioperative risk factors of patients with interstitial lung disease after pulmonary resection.
    Huang C; Sun YG; Ma C; Jiao P; Wu QJ; Tian WX; Yu HB; Tong HF
    J Cardiothorac Surg; 2024 Feb; 19(1):72. PubMed ID: 38331909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?
    Tang H; Ren Y; She Y; Dai C; Wang T; Su H; Sun W; Jiang G; Chen C
    Ther Adv Respir Dis; 2020; 14():1753466620971137. PubMed ID: 33167797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer.
    Ueno F; Kitaguchi Y; Shiina T; Asaka S; Yasuo M; Wada Y; Kinjo T; Yoshizawa A; Hanaoka M
    Respiration; 2020; 99(1):9-18. PubMed ID: 31554007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of surgical lung biopsy for interstitial disease. Experience of 161 consecutive patients from a single institution in Italy.
    Rotolo N; Imperatori A; Dominioni L; Facchini A; Conti V; Castiglioni M; Spanevello A
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):251-8. PubMed ID: 26422571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
    Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    Tsutani Y; Mimura T; Kai Y; Ito M; Misumi K; Miyata Y; Okada M
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between Comorbidities and Acute Exacerbation of Interstitial Lung Disease after Primary Lung Cancer Surgery.
    Kato T; Miyoshi S; Hamada C; Sano Y; Nogami N; Yamaguchi O; Hamaguchi N
    Acta Med Okayama; 2023 Jun; 77(3):301-309. PubMed ID: 37357631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
    Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
    Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-associated Acute Exacerbation of Interstitial Lung Disease Shortens Survival Especially in Small Cell Lung Cancer.
    Nakao S; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Anticancer Res; 2019 Oct; 39(10):5725-5731. PubMed ID: 31570474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ILD-NSCLC-GAP index scoring and staging system for patients with non-small cell lung cancer and interstitial lung disease.
    Kobayashi H; Naito T; Omae K; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Murakami H; Endo M; Takahashi T
    Lung Cancer; 2018 Jul; 121():48-53. PubMed ID: 29858026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
    Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
    PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ATS/ERS/JRS/ALAT statement "IPF by HRCT" could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer.
    Asai N; Katsuda E; Hamanaka R; Kosaka K; Matsubara A; Nishimura M; Tanaka H; Yokoe N; Takahashi A; Yamaguchi E; Kubo A
    Tumori; 2017 Jan; 103(1):60-65. PubMed ID: 27791236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of collagen vascular disease-associated interstitial lung disease on the outcomes of lung cancer surgery.
    Maeda H; Kanzaki M; Sakamoto K; Isaka T; Oyama K; Murasugi M; Onuki T
    Surg Today; 2017 Sep; 47(9):1072-1079. PubMed ID: 28247107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer.
    Enomoto Y; Inui N; Kato T; Baba T; Karayama M; Nakamura Y; Ogura T; Suda T
    Lung Cancer; 2016 Jun; 96():63-7. PubMed ID: 27133752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of Stage I-II Non-Small Cell Lung Cancer in Patients With Interstitial Lung Disease: A Multicenter Retrospective Study.
    Fintelmann FJ; Graur A; Oueidat K; Simon J; Barnes JMH; McDermott S; Genshaft SJ; Healey TT; Suh RD; Maxwell AWP; Abtin F
    AJR Am J Roentgenol; 2024 Feb; 222(2):e2330300. PubMed ID: 37966037
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical resection of lung cancer in patients with underlying interstitial lung disease.
    Martinod E; Azorin JF; Sadoun D; Destable MD; Le Toumelin P; Longchampt E; Kambouchner M; Guillevin L; Valeyre D
    Ann Thorac Surg; 2002 Oct; 74(4):1004-7. PubMed ID: 12400736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the clinical features of lung cancer in patients with connective tissue diseases.
    Saijo A; Hanibuchi M; Goto H; Toyoda Y; Tezuka T; Nishioka Y
    Respir Investig; 2017 Mar; 55(2):153-160. PubMed ID: 28274531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival.
    Barczi E; Nagy T; Starobinski L; Kolonics-Farkas A; Eszes N; Bohacs A; Tarnoki AD; Tarnoki DL; Müller V
    Thorac Cancer; 2020 Jul; 11(7):1911-1917. PubMed ID: 32401433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.